Skip to main content

Table 4 CIMP Proportion in samples with both methylation and gene expression data. This table shows the number of CIMP-positive and CIMP-negative samples characterized by both methylation and gene expression data, for each cancer type, as well as the proportion of CIMP-positive samples

From: Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype

Tissue

Negative

Positive

Ratio (%)

Bladder

27

16

37

Breast

385

93

20

Colon

27

7

20

Lung

22

60

75

Stomach

131

178

58

Overall

592

354

37